Cholecystokinin Receptor

Cholecystokinin Receptor 관련 제품 (105):

By Effects:	Inhibitors (5) Agonists (16) Antagonists (56) Activators (2) Modulator (1) Chemical (1) Controls (2)

Cat. No.	상품명	효과	Purity

HY-P3446A

Big Gastrin I (human) TFA
Big Gastrin I, human (TFA) is a gastrointestinal hormone consisting of 34 amino acids. Big Gastrin I, human (TFA) can be used as a potential substance for the study of cancer, autoimmune diseases, fibrotic diseases, inflammatory diseases, neurological diseases or cardiovascular diseases.

HY-106840A

L-365260 hemihydrate	Antagonist	99.75%
L-365260 hemihydrate is an orally active and selective antagonist of non-peptide gastrin and brain cholecystokinin receptor (CCK-B), with K_is of 1.9 nM and 2.0 nM, respectively. L-365260 hemihydrate interacts in a stereoselective and competitive manner with guinea pig stomach gastrin and brain CCK receptors.

HY-118194

A-65186	Antagonist	99.94%
A-65186 is a CCK-A receptor antagonist with the activity of inhibiting CCK8-induced amylase secretion. A-65186 has high binding affinity for pancreatic CCK-A receptors, is more than 500 times more selective for CCK-A receptors than for CCK-B receptors, and can inhibit CCK8-induced amylase secretion.

HY-P1806

Gastrin I (1-14), human		98.25%
Gastrin I (1-14), human is 1-14 fragment of human gastrin I peptide. Gastrin I is an endogenous, gastrointestinal peptide hormone. Gastrin is the major hormonal regulator of gastric acid secretion.

HY-U00360

(Rac)-Sograzepide	Antagonist	98.98%
(Rac)-Sograzepide is an antagonist of cholecystokinin B (CCK-B) receptor, and has the potential of reducing the secretion of gastric acid.

HY-P5413

[Lys3]-Bombesin		99.39%
[Lys3]-Bombesin is a biological active peptide. (PET (Positron Emission Tomography) imaging of [Lys3]-bombesin is able to detect gastrin-releasing peptide receptor (GRPR) positive prostate cancer. An immunoconjugate of [Lys3]-bombesin and corresponding monoclonal antibody can specifically induce (CD64)-dependent monocyte and neutrophil-mediated lysis of small cell carcinoma.)

HY-105226B

CI-988 hemihydrate	Antagonist	≥99.0%
CI-988 hemihydrate (PD134308) is a potent, selective and orally active CCK2R (cholecystokinin 2 receptor) antagonist with an IC₅₀ of 1.7 nM for mouse cortex CCK2. CI-988 hemihydrate shows >1600-fold selectivity for CCK2 over CCK1 receptor. CI-988 hemihydrate has anxiolytic and anti-tumor effects.

HY-P2677

CCK (26-31) sulfated
CCK (26-31) (sulfated) is the N-terminal fragment of CCK, a peptide hormone found in the gut and brain that stimulates digestion, regulates satiety, and is associated with anxiety.

HY-P0196A

Cholecystokinin Octapeptide, desulfated TFA
Cholecystokinin Octapeptide, desulfated (CCK Octapeptide, desulfated) TFA is a synthetic desulfated Cholecystokinin octapeptide (HY-P0093).

HY-P1593A

Mini Gastrin I, human TFA		98.13%
Mini Gastrin I, human (TFA) is a shorter version of human gastrin, consists of amino acids 5-17 of the parent peptide.

HY-P2932A

Cholecystokinin-33 free acid
Cholecystokinin-33 free acid is an analogue of Cholecystokinin (HY-P2932). C-terminal amidation is important for binding of Cholecystokinin to its receptors, and removing the amide group would decrease Cholecystokinin activity. Cholecystokinin-33 free acid can be used to study C-terminal amidation of Cholecystokinin-33.

HY-U00062

Tarazepide	Antagonist
Tarazepide is a potent and specific CCK-A receptor antagonist.

HY-100481

RP 72540	Antagonist
RP 72540 is a selective CCK-B receptor antagonist, with IC₅₀ values of 2.4, 1.2, and 3.8 nM for CCK-B receptors in the guinea pig cerebral cortex, rat cerebral cortex, and mouse brain, respectively. RP 72540 effectively inhibits CCK-8-induced neuronal firing and dose-dependently inhibits gastric acid secretion, making it potentially valuable in studies of acid secretion. RP 72540 is an important tool for investigating the physiological functions of CCK B receptors.

HY-177507

FE101120	Agonist
FE101120 is a non-peptide agonist CCK2 receptor agonist. FE101120 can be used for the study of diabetes.

HY-150036

Anthramycin	Antagonist
Anthramycin, a member of the pyrolobenzodiazepine (PBD) family, is a potent antibiotic. Anthramycin has potent antitumor activity. Anthramycin can act as an potent antagonist of cholecystokinin in the central nervous system in mice.

HY-117437

Azintamide	Modulator
Azintamide (Bilipurum) can be used for the research of psoriasis vulgaris, dyspepsia and other conditions.

HY-114966

RP73870	Antagonist
RP73870 is an orally active gastrin/cholecystokinin-B receptor antagonist. RP73870 inhibits basal gastric acid secretion in the rat. RP73870 has potent anti-ulcer activity.

HY-118314

CI-1015
CI-1015 is a potent CCK-B receptor antagonist.

HY-P2592

Ro 23-7014
Ro 23-7014 is an appetite suppressant. Ro 23-7014 is an analog of cholecystokinin (CCK-7).

HY-P1593

Mini Gastrin I, human
Mini Gastrin I, human is a shorter version of human gastrin, consists of amino acids 5-17 of the parent peptide.

Name
이메일 *

	Sorry, but the email address you supplied was invalid.